Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | decreased circulating cholesterol level | induced | IAGP | controlled cholesterol content diet and controlled fat content diet | 629577 | compared to control BC/CpbU males | RGD | | hyperlipidemia | | QTM | | 629577 | | RGD | | increased body weight | | QTM | | 629577; 629577 | | RGD | | increased body weight | | IAGP | | 629577 | compared to BC/CpbU | RGD | | increased body weight | sexual_dimorphism | IAGP | | 629577 | compared to LEW/OlaHsd females | RGD | | increased circulating aldosterone level | induced | IAGP | controlled cholesterol content diet and controlled fat content diet | 629577 | compared to treated LEW/OlaHsd | RGD | | increased circulating aldosterone level | | QTM | | 629577; 629577 | | RGD | | increased circulating cholesterol level | induced | IAGP | controlled cholesterol content diet and controlled fat content diet | 629577 | compared to LEW/OlaHds and treated BC/CpbU | RGD | | increased circulating cholesterol level | | QTM | | 629577; 629577; 629577; 629577 | | RGD | | increased circulating phospholipid level | induced | IAGP | controlled cholesterol content diet and controlled fat content diet | 629577 | compared to treated BC/CpbU | RGD | | |